These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 3006396)

  • 1. [Morphology, topography and growth pattern of benign proliferative breast lesions and pre-invasive cancers].
    Böcker W; Jarasch ED; Nagle EB; Höhne R
    Verh Dtsch Ges Pathol; 1985; 69():96-107. PubMed ID: 3006396
    [No Abstract]   [Full Text] [Related]  

  • 2. Definition of precancerous and high-risk mammary lesions.
    Bégin LR
    Can J Surg; 1985 May; 28(3):248-51. PubMed ID: 2986807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pre-invasive tumors and precancerous conditions of the breast: pathologico-anatomic demarcation and clinical consequences].
    Bässler R; Werner J
    Chirurg; 1984 Mar; 55(3):133-41. PubMed ID: 6325099
    [No Abstract]   [Full Text] [Related]  

  • 4. New aspects of the natural history of in situ and invasive carcinoma in the female breast. Results from autopsy investigations.
    Andersen J; Nielsen M; Christensen L
    Verh Dtsch Ges Pathol; 1985; 69():88-95. PubMed ID: 3006395
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pathology of premalignant and malignant diseases of the female breast].
    Prechtel K
    Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir; 1989; ():897-900. PubMed ID: 2577661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Significance of hyperelastosis in proliferative lesions of the breast].
    Cuccurullo L; Giordano GG; Mineo A; Iaccarino M; Battista O; Cattaneo L; Ferraraccio F
    Pathologica; 1984; 76(1041):89-101. PubMed ID: 6087264
    [No Abstract]   [Full Text] [Related]  

  • 7. [Immunocytochemical demonstration of actin in myothelial cells in proliferative diseases of the breast].
    Walther B; Rutter G; Stegner HE; Böcker W
    Pathologe; 1986 Nov; 7(6):318-23. PubMed ID: 3027685
    [No Abstract]   [Full Text] [Related]  

  • 8. [Morphological diagnosis and prognosis in early ductal breast cancer].
    Frank GA; Volchenko NN
    Vopr Onkol; 1992; 38(3):299-310. PubMed ID: 1338666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Benign and premalignant breast lesions--clinico-pathological correlation].
    Afek A; Shibi R; Kopolovitz G
    Harefuah; 1997 Nov; 133(9):375-8. PubMed ID: 9418343
    [No Abstract]   [Full Text] [Related]  

  • 10. Benign and malignant proliferative epithelial lesions of the breast; a review.
    Azzopardi JG
    Eur J Cancer Clin Oncol; 1983 Dec; 19(12):1717-20. PubMed ID: 6319145
    [No Abstract]   [Full Text] [Related]  

  • 11. The pathologic profile of invasive breast cancer-ii) changes in the harboring mammary tissue and regional lymphnodes.
    Mehtani VG; Joshi K; Mehrotra GC
    Indian J Pathol Microbiol; 1987 Oct; 30(4):415-22. PubMed ID: 2853136
    [No Abstract]   [Full Text] [Related]  

  • 12. [Definition and development of "borderline" lesions in breast cancer. Atypical hyperplasia and carcinoma "in situ"].
    Contesso G
    J Gynecol Obstet Biol Reprod (Paris); 1980; 9(1):101-2. PubMed ID: 7451846
    [No Abstract]   [Full Text] [Related]  

  • 13. Pathologic considerations in the high-risk breast patient.
    Simmons R; Serafin D; McCarty K
    Clin Plast Surg; 1988 Oct; 15(4):655-65. PubMed ID: 2852084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for premalignant lesions in the human breast.
    Sloane JP
    Eur J Cancer Prev; 1993 Nov; 2 Suppl 3():17-21. PubMed ID: 8298446
    [No Abstract]   [Full Text] [Related]  

  • 15. [The precancerous lesions of the female breast: clinical and therapeutic considerations (author's transl)].
    Schreiner WE; Genton C
    Schweiz Rundsch Med Prax; 1982 Apr; 71(14):582-8. PubMed ID: 6283516
    [No Abstract]   [Full Text] [Related]  

  • 16. [Histologic classification of breast cancer and its precancerous stages].
    Nizze H
    Zentralbl Gynakol; 1987; 109(1):3-14. PubMed ID: 3033949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 17 beta-Hydroxysteroid dehydrogenase type 1 and type 2 in ductal carcinoma in situ and intraductal proliferative lesions of the human breast.
    Ariga N; Moriya T; Suzuki T; Kimura M; Ohuchi N; Satomi S; Sasano H
    Anticancer Res; 2000; 20(2B):1101-8. PubMed ID: 10810403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Procedures of analytic morphometry in the monitoring of nuclear changes of breast ductal epithelium from normal to carcinoma].
    Giardina C; Serio G; Potente F; Pennella A; Lettini T; Di Tolve P; Ricco R; Pesce Delfino V
    Pathologica; 1992; 84(1094):97-100. PubMed ID: 1338654
    [No Abstract]   [Full Text] [Related]  

  • 19. [Histopathology of the breast with reference to consultant studies. I. An analysis of 1,339 cases on the breast register of the Fulda Pathologic Institute].
    Bässler R; Schneider B; Scheidt E
    Pathologe; 1989 May; 10(3):135-41. PubMed ID: 2544865
    [No Abstract]   [Full Text] [Related]  

  • 20. [Significance of proliferative breast lesions around breast cancers].
    Moriya T; Manabe T; Sakurai T; Sakamoto K
    Gan To Kagaku Ryoho; 1995 Apr; 22 Suppl 1():42-5. PubMed ID: 7747991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.